Table 2.
Clinical characteristics of study subjects.
| Measurement | Insulin sensitive N = 12; 8 female, 4 male Mean ± SEM (range) | Insulin resistant N = 15; 12 female, 3 male Mean ± SEM (range) | P |
|---|---|---|---|
| Age (years) | 47.9 ± 4.0 (26–64) | 49.3 ± 2.8 (29–68) | NS |
| BMI (kg/m2) | 26.0 ± 0.72 (23.3–32.6) | 35.1 ± 0.9 (27.5–41.8) | <0.0001 |
| SI | 4.64 ± 0.33 (2.49–7.12) | 1.55 ± 0.30 (0.56—2.34) | <0.0001 |
| Fasting glucose (mg/dL) | 84.4 ± 1.7 (73–96) | 88.4 ± 2.2 (78–109) | NS |
| Fasting insulin (μIU/mL) | 6.4 ± 0.97 (3.3–13.1) | 12.5 ± 2.5 (5.1–42.1) | <0.05 |
| Triglycerides (mg/dL) | 111.6 ± 17.9 (57–255) | 157.4 ± 15.5 (69–328) | 0.06 |
| HDL (mg/dL) | 70.5 ± 8.0 (38–126) | 46.7 ± 2.4 (29–66) | <0.01 |
| LDL (mg/dL) | 124.4 ± 12.0 (72–207) | 117.8 ± 6.0 (77–166) | NS |
| Systolic BP (mmHg) | 125.9 ± 5.9 (103–174) | 127 ± 4.6 (98–163) | NS |
| Diastolic BP (mmHg) | 75.7 ± 3.2 (58–92) | 76.7 ± 2.9 (56–96) | NS |
| VO2max (mL/kg*min) | 33.7 ± 2.5 (22.9–53.2) | 22.2 ± 1.2 (13.8–29.3) | <0.001 |
| IPAQ activity score | 2945 ± 805 (318–9782) | 1335 ± 958 (186–2946) | 0.08 |